Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

ABT-431 evaluated in Parkinson's patients

May 6, 1997

Progress report on Cypros's adenosine and neuronal calcium channel preclinical programs

May 6, 1997

Neurotrophic factor gene therapy shows promise for motor neuron diseases

May 6, 1997

Daiichi and Fuji prepare new analgesics

May 6, 1997

AMPA/NMDA receptor antagonists from Rhone-Poulenc Rorer

May 6, 1997

Hyal's Oralease receives Emergency Drug Release status in Canada

May 5, 1997

Synthelabo develops alternative to AChE inhibitors for AD

May 5, 1997

Pierre Fabre prepares agents with antidopaminergic/antiserotonergic effects

May 5, 1997

Preclinical results for N-3389 in emesis

May 5, 1997

Agents specific for dopamine D3 receptors described by Neurogen

May 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...